Molecular Imaging Corp. this week announced its revenues for the fiscal quarter ending December 31, 2004. Revenues were reported at $5 million, compared with $5.6 million in the second quarter of FY03. For the sixth month period, revenues decreased 11 percent to $10 million, compared with $11.2 million in the year-ago period.
   
Molecular Imaging attributed 75 percent of its decline in revenues to the election by many of its customers over the course of 2004 to buy FDG direct from third party suppliers instead of including the FDG in the price of the service as they did during the six months ending December 31, 2003.